Media & News
Septa-Citalopram and Septa-Amlodipine now available in provinces of Saskatchewan, Alberta, and New Brunswick
FOR IMMEDIATE RELEASE MISSISSAUGA, ONTARIO - SEPTEMBER 19, 2019 - Septa Pharmaceuticals, Inc. today announced the listing of two of its generic pharmaceutical drugs in the provincial formularies of Saskatchewan, Alberta, and New Brunswick. Septa-Citalopram, an Anti-depressant belonging to the pharmaceutical class of Selective Serotonin Reuptake Inhibitors (SSRIs) and used in the treatment of symptoms related to major depression is available in two strengths - 20mg and 40mg in pack sizes of 100 and 500 tablets, respectively in all of the three provinces. Septa-Amlodipine, an Anti-hypertensive/Anti-Anginal belonging to the pharmaceutical class of Calcium Channel Blocker is available in three strengths - 2.5mg, 5.0mg, and 10.0mg with pack sizes varying from 100, 250, and 500 tablets. All three strengths are available in all three provinces. Last week, Septa Pharmaceuticals proudly announced the listing of its products in three other provinces - Ontario, Quebec, and British Columbia - after only being in the market for less than two years. “I am extremely proud and delighted with the listing of our products in 3 additional provinces,†said Devinder Kumar, President and CEO of Septa Pharmaceuticals, Inc. “Our formulary listing in Ontario, Quebec, and British Columbia has undoubtedly set the momentum for us to successfully achieve this feat. This achievement not only reiterates the strength and dedication of our team, but also permits us to gain a small yet substantial foothold in some of the big Canadian generic markets.†Pharmacists, wholesalers, distributors, and other health care professionals can now place orders for the two products by visiting Septa Pharmaceuticals’ website on the World Wide Web at www.septapharmaceuticals.com and viewing current and upcoming products. For additional information on the listing of Septa Pharmaceuticals’ products, please visit the following provincial formularies. ABOUT SEPTA PHARMACEUTICALS, INC. Septa Pharmaceuticals, Inc. is proudly a Canadian owned and operated generic pharmaceutical company. The company provides quality generic pharmaceuticals and healthcare products for domestic and global pharmaceutical and health care markets. For more information, visit www.septapharmaceuticals.com MEDIA CONTACT Septa Pharmaceuticals, Inc. Public Relations Manager +1.905.564.5665 pr@septapharma.com |